Finoriq research workspace
Schrodinger, Inc. (SDGR) Institutional Holdings & 13F Ownership
Schrödinger, Inc. develops physics-based computational platform that enables discovery of. Review SDGR institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
- Company
- Schrodinger, Inc. (SDGR)
- Ticker
- SDGR
- Market Cap
- $1.1B
- Latest Price
- $15.19
- Industry
- Biotech & Pharma
Schrodinger, Inc. (SDGR) Top Institutional Holders
Top current 13F holders indexed for Schrodinger, Inc. (SDGR). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | Bill GatesCIK 0001166559 | $79.3M | 0.25% | Filing2026-05-15 |
| 2 | Joel GreenblattCIK 0001510387 | $408,653 | 0.0% | Filing2026-05-15 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.